LAUSR

Abstract Aims and Objectives Long COVID is defined as the continuation of symptoms for four or more weeks after initial contraction of the virus. This review article examines the role of four select micronutrients (zinc, vitamins C, D and polyphenols) for their anti‐inflammatory and therapeutic potential to improve sleep‐related symptoms in persons with long COVID. Background Evidence suggests a link between long COVID and increased inflammation. There are currently no therapeutic interventions for common sleep‐related symptoms associated with long COVID. Micronutrients, due to their antioxidant and anti‐inflammatory properties, may have a role in the treatment of sleep‐related symptoms in the context of long COVID. Design A narrative literature review was conducted and guided by the PRISMA checklist. Methods All articles were screened from PubMed, ScienceDirect, NCBI or Google Scholar and were limited to human studies. The following keywords were used: ‘COVID‐19’, ‘sleep symptoms’, ‘zinc’, ‘vitamin C’, ‘vitamin D’, ‘polyphenols’ and ‘micronutrients’. Results There are currently no studies that examine the usage of micronutrients and its impacts on long‐term, sleep‐related symptoms post‐COVID‐19 infection. We focussed our review on prior studies that examined micronutrients in the context of sleep symptoms and inflammation, while exploring the potential for micronutrients to help improve sleep‐related symptoms associated with long COVID. Conclusions There is evidence to suggest that sleep‐related symptoms associated with long COVID, such as fatigue and poor sleep quality, are associated with inflammation. Zinc, vitamins C, D and polyphenols all have the potential to improve both inflammation and sleep quality to alleviate symptoms. Future research should further examine these micronutrients in the context of long COVID to improve sleep and quality of life. Relevance to Clinical Practice This article provides implications for clinicians to be at the forefront of research on the usage of micronutrients to improve sleep‐related symptoms in persons with long COVID.